top of page

Jurkat NF-κB-Luciferase Reporter Cell Line

Item
Cat#
Price

Stable Cell Line

SNB-SP-0007

$1,980

Compound Test Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The NF-κB (Nuclear Factor Kappa B) signaling pathway is a central pathway regulating inflammation, immunity, cell survival, and proliferation. In its inactive state, NF-κB (typically a p50/p65 dimer) is bound to the inhibitory protein IκB and sequestered in the cytoplasm. Upon cellular stimulation by external signals (e.g., TNF-α, bacterial LPS), the IκB kinase (IKK) complex is activated, leading to phosphorylation and subsequent ubiquitin-mediated degradation of IκB. The released NF-κB then translocates into the nucleus, where it binds to specific DNA sequences to initiate the transcription of various target genes (such as cytokines, chemokines, and anti-apoptotic proteins), thereby participating in immune responses, inflammatory reactions, and tumorigenesis. 

 

Screeningbio’s Jurkat/NF-κB/Luciferase reporter gene cell line stable transfected with NF-κB response element and luciferase gene. Upon stimulated, NF-κB pathway was activated and induce luciferase expression.


Product Specifications

Target Type

Signal Pathway

Species

Human

HGNC Symbol


Accession Number


Parental Line

Jurkat

Lot#

See Vial

Storage

Liquid Nitrogen


Data

Jurkat/NF-κB/Luciferase Agonist Assay. Jurkat/NF-κB/Luciferase reporter cells were treated with TNFα. The assay was run based on Promega ONE-GLO Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
Jurkat/NF-κB/Luciferase Agonist Assay. Jurkat/NF-κB/Luciferase reporter cells were treated with TNFα. The assay was run based on Promega ONE-GLO Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.



Target Background


The NF-κB (Nuclear Factor Kappa B) signaling pathway is a central pathway regulating inflammation, immunity, cell survival, and proliferation. In its inactive state, NF-κB (typically a p50/p65 dimer) is bound to the inhibitory protein IκB and sequestered in the cytoplasm. Upon cellular stimulation by external signals (e.g., TNF-α, bacterial LPS), the IκB kinase (IKK) complex is activated, leading to phosphorylation and subsequent ubiquitin-mediated degradation of IκB.


The released NF-κB then translocates into the nucleus, where it binds to specific DNA sequences to initiate the transcription of various target genes (such as cytokines, chemokines, and anti-apoptotic proteins), thereby participating in immune responses, inflammatory reactions, and tumorigenesis. 



Product Documentation



Related Products


Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page